Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide M-M-R II vaccine vials. The contract has a potential value of $3,245.70 and a completion date of February 12, 2024. This contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC has a potential value of $999,999,999.00 and a performance period through December 31, 2025. No set-aside designation was used for this award.
Generated 5/10/24, 10:58 AM